文传商讯
Amylyx Pharmaceuticals Receives Negative CHMP Opinion on its Marketing Authorisation Application for
2023-10-16 22:03:48
ELIUD KIPCHOGE VISITS INEOS IN SHANGHAI AND UNVEILS CHINA’S FIRST INEOS 1:59 PACE CHALLENGE POSTS
2023-10-16 22:03:48
Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action
2023-10-12 19:00:08
SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers
2023-10-12 19:00:08
